Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MDAI Stock Forecast 2025-2026
$1.97
Current Price
$50.72M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MDAI Price Targets
+278.2%
To High Target of $7.45
+153.8%
To Median Target of $5.00
+1.5%
To Low Target of $2.00
MDAI Price Momentum
-11.3%
1 Week Change
+42.8%
1 Month Change
+22.4%
1 Year Change
-30.4%
Year-to-Date Change
-39.4%
From 52W High of $3.25
+139.1%
From 52W Low of $0.82
📊 TOP ANALYST CALLS
Did MDAI Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Spectral Ai is one of their latest high-conviction picks.
Latest MDAI Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, MDAI has a bullish consensus with a median price target of $5.00 (ranging from $2.00 to $7.45). Currently trading at $1.97, the median forecast implies a 153.8% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MDAI Analyst Ratings
3
Buy
0
Hold
0
Sell
MDAI Price Target Range
Low
$2.00
Average
$5.00
High
$7.45
Current: $1.97
Latest MDAI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MDAI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 2, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.50 |
| Mar 18, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.50 |
| Aug 13, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.50 |
| Aug 12, 2024 | Northland Capital Markets | Carl Byrnes | Outperform | Initiates | $6.00 |
| Jul 18, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Initiates | $3.50 |
| Jan 23, 2024 | BTIG | Ryan Zimmerman | Buy | Initiates | $4.00 |
Spectral AI Inc. (MDAI) Competitors
The following stocks are similar to Spectral Ai based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Spectral AI Inc. (MDAI) Financial Data
Spectral AI Inc. has a market capitalization of $50.72M with a P/E ratio of 29.7x. The company generates $29.96M in trailing twelve-month revenue with a -30.7% profit margin.
Revenue growth is +6.0% quarter-over-quarter, while maintaining an operating margin of -13.4% and return on equity of +211.2%.
Valuation Metrics
Market Cap
$50.72M
Enterprise Value
$50.54M
P/E Ratio
29.7x
PEG Ratio
-3.5x
Price/Sales
1.7x
Growth & Margins
Revenue Growth (YoY)
+6.0%
Gross Margin
+47.2%
Operating Margin
-13.4%
Net Margin
-30.7%
EPS Growth
+6.0%
Financial Health
Cash/Price Ratio
+27.7%
Current Ratio
1.4x
Debt/Equity
-6.0x
ROE
+211.2%
ROA
-18.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Spectral AI Inc. (MDAI) Business Model
About Spectral AI Inc.
What They Do
Develops advanced imaging systems and AI applications.
Business Model
The company generates revenue by providing its proprietary imaging technology and AI solutions to healthcare providers, including hospitals and clinics. Its focus on improving medical diagnostics, particularly for burn and chronic wounds, positions it as a crucial partner in enhancing patient care and outcomes.
Additional Information
Spectral AI's technology allows for real-time, non-invasive assessments, which can significantly improve decision-making in medical settings. As a player in the med-tech sector, it is leveraging AI to solve complex diagnostic challenges, making it a noteworthy investment opportunity in the evolving landscape of healthcare technology.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
78
CEO
Mr. Wensheng Fan
Country
United States
IPO Year
2021
Website
www.spectral-ai.comSpectral AI Inc. (MDAI) Latest News & Analysis
Latest News
Quick Summary
Spectral AI, Inc. (Nasdaq: MDAI) showcased its AI advancements in medical diagnostics at the British Burn Association conference from June 4-6, 2025, focusing on improving burn care.
Why It Matters
Spectral AI's recognition at a major conference underscores its leadership in AI-driven medical diagnostics, potentially boosting its market position and attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Spectral AI, Inc. (Nasdaq: MDAI) has appointed Stanley Micek as Chief Operating Officer, transitioning from his role as Interim COO since May 2024, to enhance its focus on AI in medical diagnostics.
Why It Matters
Stanley Micek's appointment as COO signals stability and leadership continuity at Spectral AI, potentially boosting investor confidence in the company's strategic direction and operational execution.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Spectral AI, Inc. (Nasdaq: MDAI) reported 60.8% shareholder participation at its 2025 Annual Meeting, with 15,551,068 shares represented. The company focuses on AI in medical diagnostics for wound care.
Why It Matters
High shareholder participation signals strong investor interest and confidence in Spectral AI, potentially impacting stock performance and attracting further investment in the company.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Spectral AI, Inc. (NASDAQ:MDAI) will host its Q1 2025 Earnings Conference Call on May 13, 2025, at 5:00 PM ET, featuring key company participants and analysts.
Why It Matters
Earnings calls provide insight into a company's financial health and future prospects, influencing stock prices and investor sentiment. Key discussions can impact market reactions significantly.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Spectral AI reported Q1 revenue of $6.7M and cash reserves of $14.1M. The company is on track for a De Novo FDA submission in H1 2025, focusing on AI diagnostics in wound care.
Why It Matters
Spectral AI's improved revenue and cash position signal financial health, while the upcoming FDA submission could drive future growth, impacting stock performance and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Spectral AI, Inc. (NASDAQ: MDAI) showcased its AI-driven DeepView® System at the American Burn Association meeting, attended by over 2,200 professionals, highlighting its focus on burn healing.
Why It Matters
Spectral AI's participation in a major industry event highlights its commitment to innovation and networking, potentially boosting credibility and market interest, which can positively influence stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About MDAI Stock
What is Spectral AI Inc.'s (MDAI) stock forecast for 2025?
Based on our analysis of 3 Wall Street analysts, Spectral AI Inc. (MDAI) has a median price target of $5.00. The highest price target is $7.45 and the lowest is $2.00.
Is MDAI stock a good investment in 2025?
According to current analyst ratings, MDAI has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.97. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MDAI stock?
Wall Street analysts predict MDAI stock could reach $5.00 in the next 12 months. This represents a 153.8% increase from the current price of $1.97. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Spectral AI Inc.'s business model?
The company generates revenue by providing its proprietary imaging technology and AI solutions to healthcare providers, including hospitals and clinics. Its focus on improving medical diagnostics, particularly for burn and chronic wounds, positions it as a crucial partner in enhancing patient care and outcomes.
What is the highest forecasted price for MDAI Spectral AI Inc.?
The highest price target for MDAI is $7.45 from at , which represents a 278.2% increase from the current price of $1.97.
What is the lowest forecasted price for MDAI Spectral AI Inc.?
The lowest price target for MDAI is $2.00 from at , which represents a 1.5% increase from the current price of $1.97.
What is the overall MDAI consensus from analysts for Spectral AI Inc.?
The overall analyst consensus for MDAI is bullish. Out of 3 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $5.00.
How accurate are MDAI stock price projections?
Stock price projections, including those for Spectral AI Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 15, 2025 9:08 PM UTC